Results 201 to 208 of about 22,921 (208)

Bioavailability of Azacitidine Subcutaneous Versus Intravenous in Patients With the Myelodysplastic Syndromes

Journal of Clinical Pharmacology, 2005
exaly  

Azacitidine and the beginnings of therapeutic epigenetic modulation

Expert Opinion on Pharmacotherapy, 2008
Peter G Maslak
exaly  

A pilot pharmacokinetic study of oral azacitidine

Leukemia, 2008
Guillermo Garcia-Manero
exaly  

Azacitidine

Reactions Weekly, 2018
openaire   +2 more sources

Pharmacokinetics of different formulations of oral azacitidine (CC‐486) and the effect of food and modified gastric pH on pharmacokinetics in subjects with hematologic malignancies

Journal of Clinical Pharmacology, 2014
Eric Laille, Michael Robert Savona, Bart L Scott   +2 more
exaly  

Azacitidine

Reactions Weekly, 2007
openaire   +1 more source

Azacitidine

Reactions Weekly
openaire   +1 more source

Comparison Between Decitabine and Azacitidine for the Treatment of Myelodysplastic Syndrome: A Meta-Analysis With 1392 Participants

Clinical Lymphoma, Myeloma and Leukemia, 2015
exaly